Puma Biotech (NASDAQ: PBYI) reported Q1 EPS of $0.21, $0.89 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $99.1 million versus the consensus estimate of $67.25 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.